Vitalize Trial: A Phase 2B, Open-Label, Multicenter, Randomized Parallel-Group, Two-Stage, Study Of Maveropepimut-S, Pembrolizumab, With Or Without Intermittent Low-Dose Cyclophosphamide, In R/R Dlblc
Maveropepimut-S;Pembrolizumab;Cyclophosphamide
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: Vitalize Trial: A Phase 2B, Open-Label, Multicenter, Randomized Parallel-Group, Two-Stage, Study Of Maveropepimut-S, Pembrolizumab, With Or Without Intermittent Low-Dose Cyclophosphamide, In R/R Dlblc ### Output: Maveropepimut-S;Pembrolizumab;Cyclophosphamide